4-Methoxybenzyl phenylacetate
Common Name: |
4-Methoxybenzyl phenylacetate |
IUPAC Name: |
(4-methoxyphenyl)methyl 2-phenylacetate |
Molecular Formula: |
C16H16O3 |
SMILES: |
COC1=CC=C(C=C1)COC(=O)CC2=CC=CC=C2 |
Inchi: |
1S/C16H16O3/c1-18-15-9-7-14(8-10-15)12-19-16(17)11-13-5-3-2-4-6-13/h2-10H,11-12H2,1H3 |
Inchi Key: |
VCYWCSZLXMMLLE-UHFFFAOYSA-N |
Cas No: |
102-17-0 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
256.30 |
Mass (g/mol) |
256.11 |
Molar Refractivity |
73.29 |
Net Charge |
|
HBD |
|
HBA |
3 |
Rt Bonds |
6 |
Rings |
2 |
TPSA |
35.53 |
Hetero Atoms |
3 |
Heavy Atoms |
19 |
Aromatic Heavy Atoms |
12 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
370 |
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.19 |
LogP |
2.981 |
iLOGP |
3.00 |
XLOGP3 |
3.05 |
WLOGP |
2.83 |
MLOGP |
3.04 |
ESOL Log S |
-3.42 |
ESOL Solubility (mg/ml) |
0.097 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.46 |
Ali Solubility (mg/ml) |
0.09 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-5.54 |
Silicos-IT Solubility (mg/ml) |
0 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Moderately soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.70 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.863 |
CYP1A2 Inhibitor |
1 |
CYP2C19 Inhibitor |
1 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
1 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.452 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
1 |
Estrogen Receptor Binding |
1 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
1 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |